Tyrosine and Disease progression - a phase IV clinical study of FDA data


Disease progression is reported only by a few people who take Tyrosine.

The phase IV clinical study analyzes which people take Tyrosine and have Disease progression. It is created by eHealthMe based on reports of 516 people who have side effects while taking Tyrosine from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 18, 2022

516 people reported to have side effects when taking Tyrosine.
Among them, 4 people (0.78%) have Disease progression.

What is Tyrosine?

Tyrosine has active ingredients of tyrosine. It is often used in depression. eHealthMe is studying from 604 Tyrosine users for its effectiveness, alternative drugs and more.

What is Disease progression?

Disease progression is found to be associated with 2,135 drugs and 2,042 conditions by eHealthMe.

Number of Tyrosine and Disease progression reports submitted per year:

Could Tyrosine cause Disease progression?

Gender of people who have Disease progression when taking Tyrosine *:

  • female: 25 %
  • male: 75 %

Age of people who have Disease progression when taking Tyrosine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Tyrosine *:

  1. Zoloft: 1 person, 25.00%
  2. Enalapril Maleate: 1 person, 25.00%
  3. Decadron: 1 person, 25.00%
  4. Demadex: 1 person, 25.00%
  5. Demerol: 1 person, 25.00%
  6. Digoxin: 1 person, 25.00%
  7. Diovan: 1 person, 25.00%
  8. Duoneb: 1 person, 25.00%
  9. Efudex: 1 person, 25.00%
  10. Elocon: 1 person, 25.00%

Common side effects people have besides Disease progression *:

  1. Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 1 person, 25.00%
  2. Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 1 person, 25.00%
  3. Drug Dependence: 1 person, 25.00%
  4. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 25.00%
  5. Eye Disorder: 1 person, 25.00%
  6. Eye Pruritus (eye itching): 1 person, 25.00%
  7. Face Oedema (swelling of face): 1 person, 25.00%
  8. Fainting (loss of consciousness and postural tone): 1 person, 25.00%
  9. Fall: 1 person, 25.00%
  10. Fever: 1 person, 25.00%

Common conditions people have *:

  1. Renal Cell Carcinoma (a kidney cancer): 2 people, 50.00%
  2. Hallucinations (sensations that appear real but are created by your mind): 1 person, 25.00%
  3. Delusion (a false belief or opinion): 1 person, 25.00%
  4. Cardiomyopathy (weakening of the heart muscle): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tyrosine and have Disease progression?

Check whether Disease progression is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Disease progression and when was it recovered:

Expand to all the drugs that have ingredients of tyrosine:

Alternative drugs to, pros and cons of Tyrosine:

Disease progression treatments and more:

COVID vaccines that are related to Disease progression:

Common drugs associated with Disease progression:

All the drugs that are associated with Disease progression:

Common conditions associated with Disease progression:

All the conditions that are associated with Disease progression:

How the study uses the data?

The study uses data from the FDA. It is based on tyrosine (the active ingredients of Tyrosine) and Tyrosine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: